'Our mission to build an IO community to improve patient care'. A network for all healthcare professionals caring for patients recieving Immunotherapy.
Day 2 of the Immuno-Oncology Clinical Network national meeting in London continues with productive discussions focused on shaping a National Framework for the comprehensive management of immune-related adverse events (irAEs) associated with immune checkpoint inhibitor immunotherapies.
Over the past two days, Clinicians Pharmacists and Nurses from across the UK have collaborated to share expertise, identify priorities, and explore how we can deliver safer, more consistent care for patients receiving immunotherapy treatments.
Our collective goal remains clear: to maximise the benefits of immunotherapy while reducing the risk of serious toxicity and improving outcomes for patients nationwide.
Thank you to everyone contributing their time, expertise, and commitment to this important work.
#Immunotherapy #ImmunoOncology #PatientSafety #CancerCare #irAEs #HealthcareCollaboration #Oncology #IOCN @AOlssonBrown@Youngdr100@JohnsonA_D@UKONSmember@BOPACommittee@immunobuddies@NHSEngland@nhs
The Immuno-Oncology Clinical Network 2-day meeting in London is now underway, bringing together experts from across the UK to discuss the development of a National Framework for the comprehensive management of immune-related adverse events (irAEs) associated with immune checkpoint inhibitor immunotherapies.
Our shared aim is to ensure that patients can achieve the greatest possible benefit from these transformative treatments, while reducing the risk of serious toxicity and treatment-related complications through consistent, evidence-informed care pathways.
By collaborating nationally, we hope to strengthen patient safety, improve outcomes, and support healthcare teams in delivering high-quality immunotherapy toxicity management.
#Immunotherapy #ImmunoOncology #PatientSafety #CancerCare #irAEs #HealthcareCollaboration #Oncology #IOCN
@UKONSmember@BOPACommittee@immunobuddies
Where will the next Immuno-Oncology Clinical Network Case Conundrums take us…? 👀
We’re hitting the road again for the next instalment of challenging cases, shared learning and immuno-oncology discussion — but there’s just one question…
📍 Which city is next?
Watch the big reveal below!
🎥👇
Registration will open soon!
#IOCN #CaseConundrum #ImmunoOncology #CancerCare #MedicalEducation #HealthcareEvents #Oncology #ComingSoon @AOlssonBrown@RickyFrazer1@immunobuddies@UKONSmember@BOPACommittee
The debates have started… current session on all things reading infectious diseases and toxicity’s and the use of immunosuppressants with @AOlssonBrown@RickyFrazer1 and Dr Jonathan underwood #casecondundrums
Great poster presentation from our winning poster author Elsbeth Nye. Elsbeth presented her poster which looked at isolated immune related proctotis complicated by latent tuberculosis. Congratulations Elsbeth 👏…more to come on the rest of the award winners. #casecondundrums@AOlssonBrown@RickyFrazer1
The third session of the day was our very own @AOlssonBrown and nurse consultant and IOCN trustee Ali Hodge looking at multiple and recurrent toxicities case study’s @immunobuddies#iocn#caseconundrums
🚨New Immunobuddies Episode out now! 🎧
Episode 183: RS3PE — A WiFi password from the 90’s or an actual toxicity? (Part 3)
We’re back with the third instalment of our RS3PE mini-series — and this time we’re bringing it to life with a real clinical case.
In this episode we:
🔍 Walk through the patient presentation
🧪 Explore the investigations that were carried out
🖥️ Unpick the imaging and diagnostic clues
🧠 Show how it all led to an RS3PE diagnosis
Tune in to hear how the case unfolded and what it means for recognising RS3PE in practice.
🎧 Listen now wherever you get your podcasts.
https://t.co/HAOHIyYyzW
#ImmunoBuddies #RS3PE #Immunotherapy #irAEs #CaseStudy #Oncology #Rheumatology #Podcast
@RickyFrazer1@AOlssonBrown@IOClinicalNet@immunobuddies @UKAOSociety @UKONSmember@BOPACommittee@oncodaily@OncoDailyIO@onctrainees@ONCOassist@OncoViews@VelindreCS@OncEd@OncologyNT@myESMO@ASCO
🚨Join us on Tuesday evening:
🙌Join the Immuno-Oncology Clinical Network (IOCN) for an exclusive Spotlight Webinar with Professor Monty Pal, an internationally recognised expert in the area of genitourinary cancers, including kidney, bladder, and prostate cancer.
This session will explore strategies to optimise immunotherapy outcomes and share insights from cutting-edge clinical practice.
🎟️ Free to attend – registration required
📷 Register here: https://t.co/4fzviU16a8
@montypal@AOlssonBrown@RickyFrazer1@cityofhope@cityofhopeoc@immunobuddies@UKONSmember @UKAOSociety @BOPACommittee
#IOCN #ImmunoOncology #Immunotherapy #CancerCare #Webinar #OncologyEducation
🚨 IOCN Spotlight Webinar 🚨
📅 Tuesday 10th February
⏰ 7:00pm (UK time - GMT)
💻 Live webinar
Optimising Immunotherapy Outcomes with Professor Monty Pal (City of Hope, California)
Join the Immuno-Oncology Clinical Network (IOCN) for an exclusive Spotlight Webinar with Professor Monty Pal, an internationally recognised expert in the area of genitourinary cancers, including kidney, bladder, and prostate cancer.
This session will explore strategies to optimise immunotherapy outcomes and share insights from cutting-edge clinical practice.
🎟️ Free to attend – registration required
👉 Register here: https://t.co/Q9YFUjv8Sm
@montypal@AOlssonBrown@RickyFrazer1@cityofhope@cityofhopeoc@immunobuddies@UKONSmember @UKAOSociety @BOPACommittee
#IOCN #ImmunoOncology #Immunotherapy #CancerCare #Webinar #OncologyEducation
🎧 New Podcast Episode Out Now!
🚨The Immunobuddies – Episode 180 Impact of Diet on Immunotherapy & Practical Approaches (Final Part)
In the final episode of this diet and immunotherapy series, we’re joined by the wonderful Raiatea Van-Reenen, Immunotherapy Dietician at University Hospitals Derby, to bring together the evidence, clinical insight, and real-world practical advice.
🍽️ Topics include:
• Translating nutrition evidence into everyday immunotherapy care
• Practical, patient-centred dietary strategies
• The important role of dieticians within the immunotherapy MDT
• Supporting patients holistically alongside treatment
A must-listen for clinicians, nurses, AHPs, and anyone supporting patients on immunotherapy.
👉 Listen now: https://t.co/pSin1jcKHA
@AOlssonBrown@RickyFrazer1@UHDBTrust@IOClinicalNet@immunobuddies@myESMO@ASCO@BOPACommittee@UKONSmember @UKAOSociety @oncodaily@OncoDailyIO@onctrainees@ONCOassist@OncoViews@VelindreCS@OncEd@OncologyNT
#Immunotherapy #CancerCare #Oncology #DietAndImmunotherapy #MDTWorking #IOCN #ImmunobuddiesPodcast
🌍 World Cancer Day
Today, we want to say a heartfelt thank you to everyone across the Immuno-Oncology Clinical Network (IOCN).
We’re incredibly proud to share that IOCN has just reached 1,000 members — a huge milestone that reflects the strength, commitment, and shared purpose of this growing community.
🎉 1,000 voices, one shared goal: improving immuno-oncology care and outcomes for patients.
Every day, you support patients through increasingly complex immunotherapy pathways — managing toxicity, sharing expertise, improving services, and driving forward best practice. Your collaboration and generosity in sharing knowledge are what make the IOCN such a trusted and valuable network across the UK.
This World Cancer Day reminds us that cancer care is about people, not just disease. Thank you for the work you do — often behind the scenes — and for being part of the IOCN as we continue to learn, grow, and improve care together.
💚🧡💙💛🩷
#WORLDCANCERDAY #IOCN #ImmunoOncology #CancerCare #StrongerTogether #UNITEDBYUNIQUE #Community
@AOlssonBrown@RickyFrazer1@immunobuddies
🚨 IOCN Spotlight Webinar 🚨
📅 Tuesday 10th February
⏰ 7:00pm (UK time - GMT)
💻 Live webinar
Optimising Immunotherapy Outcomes with Professor Monty Pal (City of Hope, California)
Join the Immuno-Oncology Clinical Network (IOCN) for an exclusive Spotlight Webinar with Professor Monty Pal, an internationally recognised expert in the area of genitourinary cancers, including kidney, bladder, and prostate cancer.
This session will explore strategies to optimise immunotherapy outcomes and share insights from cutting-edge clinical practice.
🎟️ Free to attend – registration required
👉 Register here: https://t.co/Q9YFUjv8Sm
@montypal@AOlssonBrown@RickyFrazer1@cityofhope@cityofhopeoc@immunobuddies@UKONSmember @UKAOSociety @BOPACommittee
#IOCN #ImmunoOncology #Immunotherapy #CancerCare #Webinar #OncologyEducation
🎧 NEW PODCAST EPISODE 🚨
Episode 178 is now live on the Immunobuddies Podcast 🎙️
In Part 2 of our series on the Impact of Diet on Immunotherapy, we continue the conversation with Immunotherapy Dietician Raiatea Van-Reenen (University Hospital Derby), focusing on practical, real-world approaches.
This episode explores:
🥗How diet can support patients during treatment, including approaches to managing common side effects
🦠Supporting gut health, and translating emerging evidence into realistic, patient-centred advice.
The discussion highlights the importance of personalised nutrition support and multidisciplinary working in immunotherapy care.
🎙️ Listen now to Part 2 — and catch up on Part 1 if you missed it.
https://t.co/Dd7ULU9ZHK
👉 Parts 3 & 4 coming soon!
@AOlssonBrown@RickyFrazer1@UHDBTrust@IOClinicalNet@immunobuddies@myESMO@ASCO@BOPACommittee@UKONSmember @UKAOSociety
@oncodaily@OncoDailyIO@onctrainees@ONCOassist@OncoViews@VelindreCS@OncEd@OncologyNT
#Immunobuddies #Immunotherapy #OncologyNutrition #DietAndCancer #Microbiome #AlliedHealthProfessionals #PodcastSeries
🎧 NEW PODCAST EPISODE – PART 1 OF 4
We’re kicking off a brand-new 4-part series on the Impact of Diet on Immunotherapy in the latest episode of the Immunobuddies Podcast.
In Part 1, we’re joined by Immunotherapy Dietician Raiatea Van-Reenen (University Hospital Derby) to explore:
🥗 How diet interacts with the immune system
🦠 The role of the gut microbiome in immunotherapy
🧠 What the evidence really says (and what it doesn’t)
🩺 Practical, patient-centred dietary approaches during treatment
This series will break down nutrition, immunotherapy, and real-world clinical practice in a clear and practical way for healthcare professionals and patients alike.
🎙️ Listen now and stay tuned for Parts 2–4 coming soon. https://t.co/5yPCdGdJuP
@AOlssonBrown@RickyFrazer1@UHDBTrust@IOClinicalNet@immunobuddies@myESMO@ASCO@BOPACommittee@UKONSmember
@UKAOSociety @oncodaily@OncoDailyIO@onctrainees@ONCOassist@OncoViews@VelindreCS@OncEd@OncologyNT
#Immunobuddies #Immunotherapy #Dieticians #OncologyNutrition #Microbiome #CancerCare #AlliedHealthProfessionals #PodcastSeries